- Home
- NICE vs CRL Comparison
NICE vs CRL Comparison
Compare NICE & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NICE
- CRL
- Stock Information
- Founded
- NICE 1986
- CRL 1947
- Country
- NICE Israel
- CRL United States
- Employees
- NICE N/A
- CRL N/A
- Industry
- NICE Computer Software: Prepackaged Software
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- NICE Technology
- CRL Health Care
- Exchange
- NICE Nasdaq
- CRL Nasdaq
- Market Cap
- NICE 8.6B
- CRL 7.3B
- IPO Year
- NICE 1996
- CRL 2000
- Fundamental
- Price
- NICE $135.34
- CRL $168.87
- Analyst Decision
- NICE Buy
- CRL Buy
- Analyst Count
- NICE 13
- CRL 16
- Target Price
- NICE $204.46
- CRL $189.50
- AVG Volume (30 Days)
- NICE 528.8K
- CRL 969.1K
- Earning Date
- NICE 11-13-2025
- CRL 11-05-2025
- Dividend Yield
- NICE N/A
- CRL N/A
- EPS Growth
- NICE 39.25
- CRL N/A
- EPS
- NICE 8.36
- CRL N/A
- Revenue
- NICE $2,838,467,000.00
- CRL $4,028,615,000.00
- Revenue This Year
- NICE $9.20
- CRL N/A
- Revenue Next Year
- NICE $6.96
- CRL $2.11
- P/E Ratio
- NICE $16.17
- CRL N/A
- Revenue Growth
- NICE 11.39
- CRL N/A
- 52 Week Low
- NICE $127.00
- CRL $91.86
- 52 Week High
- NICE $200.65
- CRL $230.02
- Technical
- Relative Strength Index (RSI)
- NICE 37.24
- CRL 58.51
- Support Level
- NICE $137.48
- CRL $144.26
- Resistance Level
- NICE $141.10
- CRL $181.45
- Average True Range (ATR)
- NICE 3.81
- CRL 5.77
- MACD
- NICE -1.07
- CRL 2.58
- Stochastic Oscillator
- NICE 8.06
- CRL 66.93
About NICE NICE Ltd
NICE Ltd is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.